| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 1,017 | 926 | +9.7% |
| EBITDA | 16.6 | 13.9 | +19.6% |
| EBITDA margin | 1.6% | 1.5% | +0.1 pts |
| Profit before tax | 8.0 | 5.3 | +50.4% |
| Net profit | 6.1 | 3.9 | +57.6% |
| EPS | ₹0.61 | ₹0.39 | +56.4% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 353 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 136 | 136 | 33.2 | 56.3 | 107 | ||
| 383 | 383 | 276 | 331 | 422 | ||
| 600 | — | — | — | — | ||
| 4,211 | 4,120 | 3,511 | 3,020 | 3,137 | ||
| — | +17.4% | +16.3% | −3.7% | — | ||
| 39.0 | 36.3 | 36.4 | 46.2 | 55.8 | ||
| 0.9% | 0.9% | 1.0% | 1.5% | 1.8% | ||
| 28.0 | 25.3 | 24.7 | 35.8 | 48.1 | ||
| 20.7 | 18.5 | 14.8 | 1.8 | 24.1 | ||
| 0.5% | 0.5% | 0.4% | 0.1% | 0.8% | ||
| ₹2.09 | ₹1.87 | ₹1.50 | ₹0.18 | ₹2.44 | ||
| — | +24.8% | +716.6% | −92.5% | — | ||
| — | 33.8 | 17.1 | 55.6 | 92.2 | ||
| — | −8.4 | −9.7 | −12.7 | −29.4 | ||
| 25.4 | 25.4 | 7.4 | 42.9 | 62.8 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 353.3 | |
| - Cash, Equiv & ST Investments | 107.0 | 56.3 | 33.2 | 136.4 | 136.4 | |
| + Total Debt | 421.8 | 330.6 | 276.0 | 382.7 | 382.7 | |
| Enterprise Value | — | — | — | — | 599.6 | |
| Revenue | 3,136.6 | 3,019.9 | 3,510.9 | 4,120.5 | 4,210.8 | |
| Growth %, YoY | — | -3.7 | +16.3 | +17.4 | — | |
| EBITDA | 55.8 | 46.2 | 36.4 | 36.3 | 39.0 | |
| Margin % | 1.78 | 1.53 | 1.04 | 0.88 | 0.93 | |
| EBIT | 48.1 | 35.8 | 24.7 | 25.3 | 28.0 | |
| Net Income | 24.1 | 1.8 | 14.8 | 18.5 | 20.7 | |
| Margin % | 0.77 | 0.06 | 0.42 | 0.45 | 0.49 | |
| EPS, Adj (current shares) | 2.44 | 0.18 | 1.50 | 1.87 | 2.09 | |
| Growth %, YoY | — | -92.5 | +716.6 | +24.8 | — | |
| Cash from Operations | 92.2 | 55.6 | 17.1 | 33.8 | — | |
| Capital Expenditures | -29.4 | -12.7 | -9.7 | -8.4 | — | |
| Free Cash Flow | 62.8 | 42.9 | 7.4 | 25.4 | 25.4 | |
Prices at the 29 October 2026 close · figures from the company's filings with NSE
Gokul Refoils and Solvent (NSE: GOKUL) had a market capitalisation of ₹339 crore at the 29 October 2026 close (₹34.26 a share), a PE ratio of 16.4 on the last four quarters' profit and a price-to-book ratio of 0.93. In FY26 its consolidated net profit was ₹18.5 crore on revenue of ₹4,120 crore; in Q1 FY27 (April–June 2026) it was ₹6.1 crore, up 57.6% year on year. Its debt-to-equity ratio was 1.05 on 31 March 2026. Promoters held 74.00% of the shares on 30 September 2026.
Gokul Refoils and Solvent's PE ratio is 16.4 at the 29 October 2026 close (₹34.26 a share): a market capitalisation of ₹339 crore divided by consolidated net profit of ₹20.7 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹18.5 crore) it is 18.4.
Gokul Refoils and Solvent's price-to-book (PB) ratio is 0.93 at the 29 October 2026 close: a market capitalisation of ₹339 crore divided by shareholders' equity (book value) of ₹363 crore on 31 March 2026. That is a book value of ₹36.71 per share against a share price of ₹34.26.
Gokul Refoils and Solvent's book value per share was ₹36.71 on 31 March 2026: shareholders' equity of ₹363 crore divided by the 9.9 crore shares in issue, up 5.5% from ₹34.81 a year earlier. The share price at the 29 October 2026 close was ₹34.26.
Gokul Refoils and Solvent's market capitalisation was ₹339 crore at the 29 October 2026 close: 9.9 crore shares at ₹34.26 each.
No. Gokul Refoils and Solvent had borrowings of ₹383 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 1.05. Its cash and current investments were ₹185 crore, so its net debt was ₹197 crore.
Gokul Refoils and Solvent's basic earnings per share (EPS) were ₹1.87 in FY26, against ₹1.50 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹2.09.
Gokul Refoils and Solvent's debt-to-equity ratio was 1.05 on 31 March 2026: borrowings of ₹383 crore against total equity of ₹363 crore. A year earlier, on 31 March 2025, it was 0.80.
Promoters held 74.00% of Gokul Refoils and Solvent on 30 September 2026, up 0.40 percentage points from 73.60% the previous quarter and up 1.19 percentage points from 72.81% a year earlier, according to the shareholding pattern filed with NSE.
Gokul Refoils and Solvent has not yet announced the date of its Q2 FY27 results (July–September 2026); under SEBI's listing rules (Regulation 33) they are due by 14 November 2026.
Gokul Refoils and Solvent's net worth — shareholders' equity in its consolidated balance sheet — was ₹363 crore on 31 March 2026, up 5.5% from ₹345 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹339 crore at the 29 October 2026 close.
In FY26, Gokul Refoils and Solvent's return on equity (ROE) was 5.2% and its return on capital employed (ROCE) was 6.9%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 4.4% and ROCE 6.9%.
At the 29 October 2026 closing prices, on FY26 net profit, Gokul Refoils and Solvent's PE ratio is 18.4, the second highest of the four: Kriti Nutrients 9.6, Halder Venture 10.9 and M K Proteins 20.3, a peer average of 13.6. Each is the company's market capitalisation at that price divided by its FY26 net profit.
On 30 September 2026, Gokul Refoils and Solvent's shares were held by promoters 74.00%, foreign portfolio investors (FII/FPI) 0.78% and retail and other non-institutional investors 25.21%. Over the year, FII holding was up 0.49 percentage points from 0.29%.
In FY26, Gokul Refoils and Solvent generated ₹33.8 crore of cash from operations and spent ₹8.4 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹25.4 crore. In FY25 it was ₹7.4 crore.
Gokul Refoils and Solvent's latest results are for Q1 FY27 (April–June 2026), filed on 13 August 2026: consolidated net profit ₹6.1 crore, up 57.6% from ₹3.9 crore in Q1 FY26; revenue from operations ₹1,017 crore, up 9.7% year on year.
In FY26 (April 2025–March 2026), Gokul Refoils and Solvent's consolidated net profit was ₹18.5 crore, up 24.8% from ₹14.8 crore in FY25, on revenue from operations of ₹4,120 crore (up 17.4%). Over three years, from FY23, net profit was down 23.4%.
On FY26 consolidated figures, against Kriti Nutrients, Halder Venture and M K Proteins: Gokul Refoils and Solvent's operating margin of 0.6% is the lowest of the four (Kriti Nutrients 4.1%, Halder Venture 3.4%, M K Proteins 2.9%; peer average 3.4%); its return on equity of 5.2% is the lowest of the four (Kriti Nutrients 15.4%, Halder Venture 16.1%, M K Proteins 9.4%; peer average 13.6%).
In FY26, Gokul Refoils and Solvent earned net profit of ₹18.5 crore on revenue of ₹4,120 crore, against ₹33.9 crore on ₹922 crore for Kriti Nutrients. Gokul Refoils and Solvent's operating margin was 0.6% (Kriti Nutrients 4.1%) and its return on equity 5.2% (Kriti Nutrients 15.4%). At the 29 October 2026 close, Gokul Refoils and Solvent's market capitalisation was ₹339 crore against ₹324 crore for Kriti Nutrients, and its PE ratio on FY26 profit 18.4 against 9.6.
From Gokul Refoils and Solvent's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.